Keywords: chugai, licenses, japanese, rights, romark, hcv, drug

Chugai licenses Japanese rights to Romark's HCV drug nitazoxanide

Article | 23 February 2009

• Print This

Romark Laboratories, a privately-held US biopharmaceutical company, and Japanese drugmaker Chugai, a unit of Swiss drug major Roche, have entered ...

Enjoying this article? To continue reading you need to login or subscribe.